State-owned BIBCOL set to begin production of Bharat Bio's Covaxin by February 2022

The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sandeep Rathod had earlier estimated a year to start making the vaccine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/374qtWb
via IFTTT